282 related articles for article (PubMed ID: 28544102)
21. Clinical characterization and risk factors of Clostridium difficile infection in elderly patients in a Chinese hospital.
Lihua Z; Danfeng D; Cen J; Xuefeng W; Yibing P
J Infect Dev Ctries; 2015 Apr; 9(4):381-7. PubMed ID: 25881527
[TBL] [Abstract][Full Text] [Related]
22. Risk factors associated with Clostridium difficile infection in kidney transplant recipients.
Spinner ML; Stephany BR; Cerrato PM; Lam SW; Neuner EA; Patel KS
Transpl Infect Dis; 2018 Aug; 20(4):e12918. PubMed ID: 29797632
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
Messick CA; Hammel JP; Hull T
Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
[TBL] [Abstract][Full Text] [Related]
25. Molecular Epidemiology of Clostridium difficile Infection in Hospitalized Patients in Eastern China.
Jin D; Luo Y; Huang C; Cai J; Ye J; Zheng Y; Wang L; Zhao P; Liu A; Fang W; Wang X; Xia S; Jiang J; Tang YW
J Clin Microbiol; 2017 Mar; 55(3):801-810. PubMed ID: 27974547
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile infection in liver transplant recipients: a retrospective study of rates, risk factors and outcomes.
Mittal C; Hassan S; Arshad S; Jeepalyam S; Bruni S; Miceli M; Jacobsen G; Abouljoud M; Bajjoka I; Ramesh M; Alangaden G
Am J Transplant; 2014 Aug; 14(8):1901-7. PubMed ID: 24902610
[TBL] [Abstract][Full Text] [Related]
27. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.
Kyne L; Sougioultzis S; McFarland LV; Kelly CP
Infect Control Hosp Epidemiol; 2002 Nov; 23(11):653-9. PubMed ID: 12452292
[TBL] [Abstract][Full Text] [Related]
28. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
29. Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome.
Lionaki S; Panagiotellis K; Moris D; Daikos G; Psyhogiou M; Vernadakis S; Zavos G; Boletis JN
APMIS; 2015 Mar; 123(3):234-9. PubMed ID: 25556694
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
Chopra T; Alangaden GJ; Chandrasekar P
Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1113-9. PubMed ID: 20954878
[TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations of Clostridium difficile infection in a medical center in Taiwan.
Lai CC; Lin SH; Tan CK; Liao CH; Huang YT; Hsueh PR
J Microbiol Immunol Infect; 2014 Dec; 47(6):491-6. PubMed ID: 23978490
[TBL] [Abstract][Full Text] [Related]
32. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile infection: a Serbian single-center experience.
Korac M; Milosevic I; Markovic M; Popovic N; Ilic M; Markovic A; Nikolic J; Jevtovic D
J Infect Dev Ctries; 2015 Feb; 9(2):136-40. PubMed ID: 25699487
[TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile infection increases mortality risk in lung transplant recipients.
Lee JT; Kelly RF; Hertz MI; Dunitz JM; Shumway SJ
J Heart Lung Transplant; 2013 Oct; 32(10):1020-6. PubMed ID: 23891145
[TBL] [Abstract][Full Text] [Related]
35. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
Pakyz AL; Jawahar R; Wang Q; Harpe SE
J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
[TBL] [Abstract][Full Text] [Related]
36. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
37. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
[TBL] [Abstract][Full Text] [Related]
38. Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study.
Hosokawa K; Takami A; Tsuji M; Araoka H; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Matsuno N; Uchida N; Masuoka K; Wake A; Makino S; Yoneyama A; Nakao S; Taniguchi S
Transpl Infect Dis; 2014 Jun; 16(3):412-20. PubMed ID: 24810244
[TBL] [Abstract][Full Text] [Related]
39. Clinical predictors of recurrent Clostridium difficile infection in out-patients.
Shivashankar R; Khanna S; Kammer PP; Scott Harmsen W; Zinsmeister AR; Baddour LM; Pardi DS
Aliment Pharmacol Ther; 2014 Sep; 40(5):518-22. PubMed ID: 25039269
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post-transplant.
Guzman L; Qiu F; Kalil AC; Mercer DF; Langnas A; Florescu DF
Transpl Infect Dis; 2018 Apr; 20(2):e12858. PubMed ID: 29427406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
